Novonesis Launches Optiva® Triticum for Pasta Production
COPENHAGEN, Denmark, August 12, 2026 Novonesis announced the launch of Optiva® Triticum, a new biosolution designed to help pasta...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
COPENHAGEN, Denmark, August 12, 2026 Novonesis announced the launch of Optiva® Triticum, a new biosolution designed to help pasta...
NEWARK, Del., Feb. 3, 2026 — The global yeast market is entering a decisive new phase as industrial fermentation...
REYKJAVÍK, ICELAND | December 31, 2025 — Alvotech announced it has secured a USD 100 million senior term loan...
NEW YORK | December 31, 2025 — Intelligent Bio Solutions announced a strategic manufacturing partnership with Syrma Johari MedTech,...
INCHEON, South Korea; ROCKVILLE, Maryland; LONDON — December 21, 2025 — Samsung Biologics, a global contract development and manufacturing...
December 22, 2025 | Foster City, California — Gilead Sciences announced a three-year agreement with the U.S. Government designed...
December 19, 2025 | Princeton, New Jersey — Bristol Myers Squibb announced a landmark agreement with the U.S. government...
Wilmington, Del. — Nov. 21, 2025 — AstraZeneca today announced a US $2 billion investment to expand its manufacturing...
Houston, Texas – September 23, 2025 — Eli Lilly and Company (NYSE: LLY) will invest $6.5 billion to build...
